Ivax Diagnostics, Inc. (IVD) Narrows Q2 Loss
Tweet
Share
E-mailGet Alerts IVD Hot Sheet
Price: $0.53 --0%
Financial Fact:
Research and development: 160.97K
Today's EPS Names:
WPRT, ITRG, ALM, More
Financial Fact:
Research and development: 160.97K
Today's EPS Names:
WPRT, ITRG, ALM, More
Join SI Premium – FREE
Ivax Diagnostics, Inc. (NYSE: IVD) reported Q2 EPS of ($0.03), $0.02 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $4.38 million versus the consensus estimate of $4.39 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- Pliant Therapeutics, Inc. (PLRX) Misses Q2 EPS by 2c
- Mount Logan Capital Inc. (MLCI) Reports Q2 Loss of $0.37
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
